Finoriq research workspace
Autonomix Medical, Inc. (AMIX) News
Autonomix Medical, Inc. develops technology for patients with pancreatic cancer and addresses. Review AMIX recent headlines, source links, and company news on Finoriq.
Company Snapshot
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
- Company
- Autonomix Medical, Inc. (AMIX)
- Ticker
- AMIX
- Market Cap
- $2.4M
- Latest Price
- $4.36
- Industry
- Medical Devices
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.